Effects of thiabendazole (TBZ) on mitochondrial function in renal cortex of ICR mice

Food and Chemical Toxicology

Volumn 37, Issue 2-3, 1999, Pages 145-152

  Fujitani, T ^a   Tada, Y ^a   Yoneyama, M ^a  

^a TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Depression of oxidative phosphorylation; Mice; Mitochondrial dysfunction; Nephrotoxicity; Thiabendazole

Indexed keywords

ADENOSINE TRIPHOSPHATE; ISOCITRATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; TIABENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY TUBULE DAMAGE; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEMATODAL AGENTS; CELL RESPIRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOCITRATE DEHYDROGENASE; KIDNEY CORTEX; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIA; THIABENDAZOLE;

EID: 0032909663     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(98)00118-5     Document Type: Article

References (27)

1. Allen P. M. and Gottlieb D. (1970) Mechanism of action of the fungicide thiabendazole, 2-(4′-thiazolyl)benzimidazole. Applied Microbiology 20, 919-926.
2. Davidson R. N., Weir W. R. C, Kaye G. L. and McIntyre N. (1988) Intrahepatic cholestasis after thiabendazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 620.
3. Ernster L. and Navazio F. (1956) The cytoplasmic distribution of isocitric dehydrogenases. Experimental Cell Research 11, 483-510.
4. Fujii T., Mikuriya H., Kamiya N. and Hiraga K. (1986) Enhancing effect of thiabendazole on urinary bladder carcinogenesis induced by sodium o-phenylphenate in F344 rats. Food and Chemical Toxicology 24, 207-211.
5. Fujitani T., Yoneyama M., Ogata A., Ueta T., Mori K. and Ichikawa H. (1991) New metabolites of thiabendazole and the metabolism of thiabendazole by mouse embryo in vivo and in vitro. Food and Chemical Toxicology 29, 265-274.
6. Gad S. C. and Weil C. S. (1982) Statistics for toxicologists. In Principles and Methods of Toxicology, ed. A. W. Hayes, pp. 273-320. Raven Press, New York.
7. Golden T. A., McElveen F. J., Jupia J. E. and Lejeune C. (1974) Hematuria following thiabendazole. Archives of Dermatology 110, 295.
8. Jones D. P. (1981) Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography. Journal of Chromatography 225, 446-449.
9. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
10. Manivel J. C., Bloomer J. R. and Snover D. C. (1987) Progressive bile duct injury after thiabendazole administration. Gastroenterology 93, 245-249.
11. Mikuriya H., Hayashida S., Takahashi H., Iguchi S. and Hiraga K. (1981) Subacute toxicity of thiabendazole by food administration to rats. Annual Report of the Tokyo Metropolitan Research Laboratory of Public Health 32-2, 5-15.
12. Nakagawa Y. and Moore G. A. (1995) Cytotoxic effects of postharvest fungicides, ortho-phenylphenol, thiabendazole and imazalil, on isolated rat hepatocytes. Life Sciences 57, 1433-1440.
13. Ogata A., Ando H., Kubo Y. and Hiraga K. (1984) Teratogenicity of thiabendazole in ICR mice. Food and Chemical Toxicology 22, 509-520.
14. Pawlowski Z. S. and Skrzypinska K. (1972) Urine precipitates during thiabendazole treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 66, 512.
15. Pedersen P. L., Greenawalt J. W., Reynafarje B., Hullihen J., Decker G. L., Soper J. W. and Bustamente E. (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods in Cell Biology 20, 411-481.
16. Rex D., Lumeng L., Eble J. and Rex L. (1983) Intrahepatic cholestasis and sicca complex after thiabendazole. Gastroenterology 85, 718-721.
17. Robinson H. J., Stoerk H. C. and Graessle O. E. (1965) Studies on the toxicologic and pharmacologic properties of thiabendazole. Toxicology and Applied Pharmacology 7, 53-63.
18. Roy M. A., Nugent F. W. and Aretz H. T. (1989) Micronodular cirrhosis after thiabendazole. Digestive Diseases and Sciences 34, 938-941.
19. Simmons C. F., Jr, Bogusky R. T. and Humes H. D. (1980) Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. Journal of Pharmacology and Experimental Therapeutics 214, 709-715.
20. Singh G. (1989) A possible cellular mechanism of cisplatin-induced nephrotoxicity. Toxicology 58, 71-80.
21. Tada Y., Fujitani T. and Yoneyama M. (1992) Acute renal toxicity of thiabendazole (TBZ) in ICR mice. Food and Chemical Toxicology 30, 1021-1030.
22. Tada Y., Fujitani T. and Yoneyama M. (1994) Thiabendazole (TBZ) nephrotoxicity and recovery in ICR adult mice. Toxicology 94, 41-55.
23. Tada Y., Fujitani T. and Yoneyama M. (1996) Subchronic toxicity of thiabendazole (TBZ) in ICR mice. Food and Chemical Toxicology 34, 709-716.
24. Tada Y., Yoneyama M., Kabashima J., Fujitani T. and Nakano M. (1989) Effects of thiabendazole on the kidneys of ICR mice. Food and Chemical Toxicology 27, 307-315.
25. Weinberg J. M., Harding P. G. and Humes H. D. (1982) Mitochondrial bioenergetics during the initiation of mercuric chloride-induced renal injury. Journal of Biological Chemistry 257, 60-67.
26. Yoneyama M., Ogata A., Fujii T. and Hiraga K. (1984) The maternal-foetal distribution of thiabendazole administered in two different vehicles to pregnant mice. Food and Chemical Toxicology 22, 731-735.
27. Yoneyama M., Ogata A., Fujii T., Mikuriya H., Yano N., Takahashi H., Yuzawa K., Ando H., Kubo Y., Nagasawa A., Nakao T. and Hiraga K. (1983) Absorption, distribution, excretion and placental transfer of thiabendazole in pregnant mice: Effect of two kinds of vehicle. Annual Report of the Tokyo Metropolitan Research Laboratory of Public Health 34, 337-342.